Skip to Content
UW Health SMPH
American Family Children's Hospital
SHARE TEXT

Request a second opinion

Ventricular Assist Device (VAD) Patient Selection Criteria

Contact Information

Heart Failure Program
(608) 253- 1690

Cardiothoracic Surgery

(608) 263-0439

Access Center for Referring Physicians
(608) 472- 0111

 

Refer a Patient Online

 

Our Providers

Left Ventricular Assist Device Providers

UW Health is one of the national leaders in outcomes using left ventricular assist devices for patients with end-stage heart failure. Our team uses a broad spectrum of left ventricular assist devices (LVAD), tailoring selection to meet each patient's individual needs.
 
Bridge-to-Transplant Candidates
 
Candidates for LVAD as a bridge-to-transplantation include heart-failure patients who are listed for heart transplantation but may require the placement of a LVAD based on the following indications:
  • Severe symptomatic heart failure despite optimal medical therapy, especially if the patient's body size and blood type suggest that the wait for a donor organ will be prolonged. Generally such patients will have a cardiac index of less than two, a pulmonary capillary wedge pressure greater than 20 or be inotrope dependent; however, each case is judged individually.
  • Severe left ventricular dysfunction and intractable arrhythmias.
  • Advanced heart failure complicated by cardiac cachexia.
  • Advanced heart failure complicated by renal or hepatic dysfunction that is felt to be secondary to poor perfusion and/or congestion.
  • Severe left ventricular dysfunction complicated by elevated pulmonary pressures not responsive to conventional agents or when these agents cannot be used or optimized due to low CO and systemic hypotension.
  • Intractable angina not responsive to medical therapy or revascularization procedures in patients with poor left ventricular function.
  • Post-cardiotomy shock.
Destination Therapy Candidates
 
Candidates for LVAD as destination therapy might require the placement of an LVAD as destination therapy based on the following indications:
  • Severe symptomatic heart failure despite optimal medical therapy in a patient who is not felt to be a candidate for heart transplantation.
  • Left Ventricular Ejection Fraction (LVEF) that is less than or equal to 25 percent.
  • Exercise VO2 that is less than or equal to 12 ml/kg/min or need for continuous intravenous inotropes or IABP therapy to prevent symptomatic hypotension, decreasing renal function or worsening pulmonary congestion.